|
Market Closed -
Nasdaq
01:30:00 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 416.18 USD | +0.45% |
|
+2.05% | +27.15% |
| 11/08 | Global drugmakers invest billions to boost US presence | RE |
| 10/08 | HSBC Adjusts Price Target on Amgen to $445 From $425, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23TCr | |||||
| 1,08800Cr | |||||
| 63TCr | - | - | - | ||
| 44TCr | |||||
| 36TCr | |||||
| 29TCr |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
